A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace) — Stella

Recruiting

Back to Phenylketonuria (PKU) trials

Trial locations(26 sites)

United States

University of Colorado, Aurora, Colorado

Emory University, Atlanta, Georgia

Northwestern University, Chicago, Illinois

Indiana University School of Medicine, Indianapolis, Indiana

Tulane University Medical Center, New Orleans, Louisiana

Key details

Sponsor

BioMarin Pharmaceutical

Enrollment target

~450 participants

Started

June 2022

Primary completion

November 2033

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov